Testing effectiveness (Phase 2)Not Yet RecruitingNCT07283900What this trial is testingAscorbate in Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndromes Prajwal Dhakal 38
Testing effectiveness (Phase 2)Study completedNCT01497145What this trial is testingA Clinical Study of KRN321 in Adult Subjects With Myelodysplastic SyndromeWho this might be right forMDS Kyowa Kirin Co., Ltd. 45
Early research (Phase 1)Study completedNCT01757639What this trial is testingIpilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+3 more National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00807677What this trial is testingDose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)UnknownNCT00242515What this trial is testingT-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)Who this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes National University Hospital, Singapore 16
Large-scale testing (Phase 3)Study completedNCT00412360What this trial is testingSingle vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)Who this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+2 more Medical College of Wisconsin 224
Large-scale testing (Phase 3)Active Not RecruitingNCT04173533What this trial is testingRandomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCTWho this might be right forAcute Myeloid LeukemiaMyelodysplasia University of Birmingham 326
Large-scale testing (Phase 3)Study completedNCT00422890What this trial is testingTreatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)Who this might be right forMyeloid LeukemiaMyelodysplastic Syndrome Technische Universität Dresden 10
Testing effectiveness (Phase 2)Study completedNCT01491958What this trial is testingSafety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell TransplantationWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome Ohio State University Comprehensive Cancer Center 40
Large-scale testing (Phase 3)Looking for participantsNCT06499285What this trial is testingElritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsWho this might be right forMyelodysplastic Syndromes Takeda 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT04668885What this trial is testingCPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDSWho this might be right forRefractory Acute Myeloid LeukemiaRelapsed Acute Myelomonocytic LeukemiaMyelodysplastic Syndromes Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385What this trial is testingHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more Center for International Blood and Marrow Transplant Research 313
Testing effectiveness (Phase 2)Study completedNCT00723099What this trial is testingDonor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+23 more Fred Hutchinson Cancer Center 73
Early research (Phase 1)Study completedNCT00498316What this trial is testingCord Blood Expansion on Mesenchymal Stem CellsWho this might be right forMyelodysplastic SyndromeLeukemia M.D. Anderson Cancer Center 98
Not applicableStudy completedNCT03894852What this trial is testingSRSF2 Gene Mutation in Patients With t-MDS/AMLWho this might be right forTherapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia Zeinab Albadry Mohammed Zahran 139
Very early researchStudy completedNCT02181478What this trial is testingIntra-Osseous Co-Transplant of UCB and hMSCWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+9 more Case Comprehensive Cancer Center 6
Early research (Phase 1)Ended earlyNCT02641002What this trial is testingCC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)Who this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes Celgene 28
Early research (Phase 1)Looking for participantsNCT07256301What this trial is testingA Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)Who this might be right forPNH - Paroxysmal Nocturnal Hemoglobinuria Shanghai Lanyi Therapeutics Co., Ltd. 24
Early research (Phase 1)Study completedNCT03755414What this trial is testingStudy of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell TransplantationWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndromes+2 more Washington University School of Medicine 55
Early research (Phase 1)Study completedNCT02203825What this trial is testingSafety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-LigandsWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeMultiple Myeloma Celyad Oncology SA 12